Emery-Dreifuss muscular dystrophy

Current Neurology and Neuroscience Reports

Volumn 7, Issue 1, 2007, Pages 78-83

  Muchir, Antoine ^b   Worman, Howard J ^a  

^a Columbia University ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EMERIN; INTERMEDIATE FILAMENT PROTEIN; LAMIN A; LAMIN C; NUCLEAR PROTEIN;

AUTOSOMAL DOMINANT DISORDER; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL FEATURE; EMERY DREIFUSS MUSCULAR DYSTROPHY; EXPERIMENTAL MODEL; GENE EXPRESSION; GENE MUTATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; HUMAN; MECHANICAL STRESS; MISSENSE MUTATION; MOUSE; MYOPATHY; NONHUMAN; PATHOGENESIS; PROTEIN LOCALIZATION; REVIEW; X CHROMOSOME LINKED DISORDER;

HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LAMIN TYPE A; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MUSCULAR DYSTROPHY, EMERY-DREIFUSS; MUTATION; NUCLEAR PROTEINS;

EID: 33846681236     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-007-0025-3     Document Type: Review

References (50)

1. Emery AE: X-linked muscular dystrophy with early contractures and cardiomyopathy (Emery-Dreifuss type). Clin Genet 1987, 32:360-367.
2. Bione S, Maestrini E, Rivella S, et al.: Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 1994, 8:323-327.
3. Manilal S, Nguyen TM, Sewry CA, et al.: The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane. Hum Mol Genet 1996, 5:801-808.
4. Nagano A, Koga R, Ogawa M, et al.: Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy. Nat Genet 1996, 12:254-259.
5. Bonne G, Di Barletta MR, Varnous S, et al.: Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 1999, 21:285-288.
6. Raffaele Di Barletta M, Ricci E, Galluzzi G, et al.: Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet 2000, 66:1407-1412.
7. McKeon FD, Kirschner MW, Caput D: Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature 1986, 319:463-468.
8. Fisher DZ, Chaudhary N, Blobel G: cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins. Proc Natl Acad Sci U S A 1986, 83:6450-6454.
9. Lin F, Worman HJ: Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem 1993, 268:16321-16326.
10. Cestan R, Lejonne P: Une myopathie avec retractions familiales. Nouv Iconogr Salpetr 1902, 15:38-52.
11. Dreifuss FE, Hogan GR: Survival in X-chromosome muscular dystrophy. Neurology 1961, 11:734-737.
12. Emery AE, Dreifuss FE: Unusual type of benign X-linked muscular dystrophy. J Neurol Neurosurg Psychiatry 1966, 29:338-342.
13. Rowland LP, Fetell M, Olarte M, et al.: Emery-Dreifuss muscular dystrophy. Ann Neurol 1979, 5:111-117.
14. Muchir A, Worman HJ: The nuclear envelope and human disease. Physiology 2004, 19:309-314.
15. Bonne G, Mercuri E, Muchir A, et al.: Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamins A/C gene. Ann Neurol 2000, 48:170-180.
16. Muchir A, Bonne G, van der Kooi AJ, et al.: Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet 2000, 9:1453-1459.
17. Fatkin D, MacRae C, Sasaki T, et al.: Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999, 341:1715-1724.
18. Waters DD, Nutter DO, Hopkins LC, et al.: Cardiac features of an unusual X-linked humeroperoneal neuromuscular disease. N Engl J Med 1975, 293:1017-1022.
19. Bialer MG, McDaniel NL, Kelly TE: Progression of cardiac disease in Emery-Dreifuss Muscular dystrophy. Clin Cardiol 1991, 14:411-416.
20. Becane HM, Bonne G, Varnous S, et al.: High incidence of sudden death of conduction system and myocardial disease due to lamins A/C gene mutation. Pace 2000, 23:1661-1666.
21. van Berlo JH, de Voogt WG, van der Kooi AJ, et al.: Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med 2005, 83:79-83.
22. Fairley EA, Kendrick-Jones J, Ellis JA: The Emery-Dreifuss muscular dystrophy phenotype arises from aberrant targeting and binding of emerin at the inner nuclear membrane. J Cell Sci 1999, 112:2571-2582.
23. Clements L, Manilal S, Love DR, et al.: Direct interaction between emerin and lamin A. Biochem Biophys Res Commun 2000, 267:709-714.
24. Sakaki M, Koike H, Takahashi N, et al.: Interaction between emerin and nuclear lamins. J Biochem 2001, 129:321-327.
25. Segura-Totten M, Kowalski AK, Craigie R, et al.: Barrier-to-autointegration factor: major roles in chromatin decondensation and nuclear assembly. J Cell Biol 2002, 158:475-485.
26. Sullivan T, Escalante-Alcalde D, Bhatt H, et al.: Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 1999, 147:913-920.
27. Östlund C, Bonne G, Schwartz K, et al.: Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy. J Cell Sci 2001, 114:4435-4445.
28. Raharjo WH, Enarson P, Sullivan T, et al.: Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy. J Cell Sci 2001, 114:4447-4457.
29. Yates JR, Wehnert M: The Emery-Dreifuss Muscular Dystrophy Mutation Database. Neuromuscul Disord 1999, 9:199.
30. Wydner KL, McNeil JA, Lin F, et al.: Chromosomal assignment of human nuclear envelope protein genes LMNA, LMNB1, and LBR by fluorescence in situ hybridization. Genomics 1996, 32:474-478.
31. Furukawa K, Inagaki H, Hotta Y: Identification and cloning of an mRNA coding for a germ cell-specific A-type lamin in mice. Exp Cell Res 1994, 212:426-430.
32. Machiels BM, Zorenc AH, Endert JM, et al.: An alternative splicing product of the lamin A/C gene lacks exon 10. J Biol Chem 1996, 271:9249-9253.
33. Sinensky M: Recent advances in the study of prenylated proteins. Biochem Biophys Acta 2000, 1484:93-106.
34. Young SG, Fong LG, Michaelis S: Prelamin A, Zmpste24, misshapen cell nuclei, and progeria--new evidence suggesting that protein farnesylation could be important for disease pathogenesis. J Lipid Res 2005, 46:2531-2558.
35. Aebi U, Cohn J, Buhle L, et al.: The nuclear lamina is a meshwork of intermediate-type filaments. Nature 1986, 323:560-564.
36. Goldman AE, Maul G, Steinert PM, et al.: Keratin-like proteins that coisolate with intermediate filaments of BHK-21 cells are nuclear lamins. Proc Natl Acad Sci U S A 1986, 83:3839-3843.
37. Worman HJ, Gundersen GG: Here come the SUNs: a nucleocytoskeletal missing link. Trends Cell Biol 2006, 16:67-69.
38. Arimura T, Helbling-Leclerc A, Massart C, et al.: Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum Mol Genet 2005, 14:155-169.
39. Mounkes LC, Kozlov SV, Rottman JN, et al.: Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. Hum Mol Genet 2005, 14:2167-2180.
40. Wang Y, Herron AJ, Worman HJ: Pathology and nuclear abnormalities in hearts of transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophy. Hum Mol Genet 2006, 15:2479-2489.
41. Ozawa R, Hayashi YK, Ogawa M, et al.: Emerin-lacking mice show minimal motor and cardiac dysfunctions with nuclear-associated vacuoles. Am J Pathol 2006, 168:907-917.
42. Melcon G, Kozlov S, Cutler DA, et al.: Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration. Hum Mol Genet 2006, 15:637-651.
43. Muchir A, van Engelen BG, Lammens M, et al.: Nuclear envelope alterations in fibroblasts from LGMD1B patients carrying nonsense Y259X heterozygous or homozygous mutation in lamin A/C gene. Exp Cell Res 2003, 291:352-362.
44. Muchir A, Medioni J, van der Kooi AJ, et al.: Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy and partial lipodystrophy carrying lamin A/C gene mutations. Muscle Nerve 2004, 30:444-450.
45. Lammerding J, Schulze PC, Takahashi T, et al.: Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 2004, 113:370-378.
46. Broers JL, Peeters EA, Kuijpers HJ, et al.: Decreased mechanical stiffness in LMNA-/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies. Hum Mol Genet 2004,13:2567-2580.
47. Lammerding J, Hsiao J, Schulze PC, et al.: Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells. J Cell Biol 2005, 170:781-791.
48. Favreau C, Higuet D, Courvalin JC, et al.: Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts. Mol Cell Biol 2004, 24:1481-1492.
49. Frock RL, Kudlow BA, Evans AM, et al.: Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. Genes Dev 2006, 20:486-500.
50. Markiewicz E, Tilgner K, Barker N, et al.: The inner nuclear membrane protein emerin regulates beta-catenin activity by restricting its accumulation in the nucleus. EMBO J 2006, 25:3275-3285.